Literature DB >> 19801183

[Infantile visceral Leishmaniasis: epidemiological, clinical and biological characteristics. About 93 case reports in the children hospital of Rabat].

L Zougaghi1, R Moutaj, L Chabaa, A Agoumi.   

Abstract

INTRODUCTION: Infantile visceral leishmaniasis (LVI) is a problem of public health in Morocco. This parasitosis rages to the state of endemic and touches the infants.
OBJECTIVES: The goal of this survey is to draw up epidemiological, clinical and biologic profile of LVI in children hospitalized in the Children's Hospital of Rabat, and to prove the contribution of serology in diagnosis of this illness.
MATERIAL AND METHODS: This retrospective study concerned all LVI cases gathered in the HER during 5 years (from 1997 to 2001). For every patient included in this study, the authors collected geographical origin, age, sex, clinical data (splenomegaly, fever, hepatomegaly, paleness), and biologic data (numeration formulates red chalk, speed of sedimentation, protein in blood and electrophoresis of the proteins). The myelogram results were also exploited as well as results of serology when they were realized.
RESULTS: Ninety-three LVI cases were listed with an age average of 3.5+/-3 years, and a sex ratio of 1.82 (p=0.032). Patients coming from farming surroundings or semi-urban were more numerous than those from cities: 85.5% versus 14.5% (p<0.0001). Most of the patients suffered from splenomegaly, fever and paleness; anaemia was almost constant. In case of hyperprotidemy (43.5%; n=27), the albumin-globulin report was always lower than 1.2. Indirect immunofluorescence was practised among 39 patients with a positive response in 84.6% of the cases. Forty patients whose serums were analyzed by indirect hemagglutination (HAI) had all a myelogram revealing the presence of protozoon, but only 57% of them showed a positive reaction in HAI.
CONCLUSIONS: These results confirm that the LVI touches children coming from underprivileged surroundings. The triad, splenomegaly, paleness and fever, is a good element of diagnostic orientation, whereas parasite revelation in bone marrow remains the best way to establish the diagnosis of this illness.

Entities:  

Mesh:

Year:  2009        PMID: 19801183     DOI: 10.1016/j.arcped.2009.05.003

Source DB:  PubMed          Journal:  Arch Pediatr        ISSN: 0929-693X            Impact factor:   1.180


  6 in total

1.  Mediterranean visceral leishmaniasis : update on biological diagnosis.

Authors:  Emna Siala; Aida Bouratbine; Karim Aoun
Journal:  Tunis Med       Date:  2022 Janvier

2.  Historical series of patients with visceral leishmaniasis treated with meglumine antimoniate in a hospital for tropical diseases, Maceió-AL, Brazil.

Authors:  Lindon Johoson Diniz Silveira; Thiago José Matos Rocha; Sandra Aparecida Ribeiro; Célia Maria Silva Pedrosa
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 Jan-Feb       Impact factor: 1.846

3.  Epidemiology of Infantile Visceral Leishmaniasis in Western Algerian And The Convenience of Serum For The Disease Diagnosis by PCR and Immunochromatography.

Authors:  Hadj Slimane Touria; Senouci Kheira; Midoun Nori; Bouchetara Assia; Laradj Amel; Bittar Fadi
Journal:  Int J Mol Cell Med       Date:  2018-03-14

4.  Epidemiology of visceral leishmaniasis in Algeria: an update.

Authors:  Amel Adel; Amel Boughoufalah; Claude Saegerman; Redgi De Deken; Zahida Bouchene; Abdelkrim Soukehal; Dirk Berkvens; Marleen Boelaert
Journal:  PLoS One       Date:  2014-06-20       Impact factor: 3.240

5.  Cost of Pediatric Visceral Leishmaniasis Care in Morocco.

Authors:  Nabil Tachfouti; Adil Najdi; Sergi Alonso; Elisa Sicuri; Abderahmane Laamrani El Idrissi; Chakib Nejjari; Albert Picado
Journal:  PLoS One       Date:  2016-06-03       Impact factor: 3.240

6.  Cost-effectiveness of diagnostic-therapeutic strategies for paediatric visceral leishmaniasis in Morocco.

Authors:  Sergi Alonso; Nabil Tachfouti; Adil Najdi; Elisa Sicuri; Albert Picado
Journal:  BMJ Glob Health       Date:  2017-08-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.